Beijing: China has reportedly approved patent for CanSino Biologics Inc’s COVID-19 vaccine — Ad5-nCOV. It is the first patent granted by China for a COVID-19 vaccine.
Saudi Arabia will be carrying out the Phase-III clinical trials for the CanSino vaccine this month.
CanSino is exploring testing the vaccine in Russia, Brazil and Chile as well. CanSino’s Hong Kong shares rose by around 14 per cent on Monday.
Also Read: First Batch Of Russian COVID-19 Vaccine To Roll Out This Month
Bhubaneswar: A Yellow warning has been issued for five Odisha districts over the next two to three hours. Light to...
Moscow: A Russian military aircraft crashed in the far eastern Amur region on Tuesday, killing six people, the country’s Defence...
Bhubaneswar: Odisha’s famed shuttler sisters Rutaparna and Swetaparna Panda excelled on the international stage yet again. A week after Rutaparna and...
Bhubaneswar: Odisha emerged runners-up in the Junior Boys’ team event at the East Zone Inter-State Team and Individual Badminton Championship 2026...
Copyright © 2026 Frontier Media
